Description of studies included in analysis

Figure A

Figure B

Figure C

Figure D



Description of studies included in analysis

Variable

% (No)

Disease:


    Acute lymphoblastic leukaemia

43 (65)

    Acute myeloblastic leukaemia

8 (12)

    Hodgkin’s disease

3 (5)

    Lymphoma

10 (15)

    Rhabdomyosarcoma

6 (10)

    Wilm’s tumour

8 (12)

    Others

22 (33)

Type of treatment:


     Neo- adjuvant

3 (4)

    Adjuvant

24 (36)

    Induction

7 (11)

    Consolidation

7 (10)

    Maintenance

39 (60)

    Supportive

2 (3)

    Definitive*

17 (26)

    Other

1 (2)

Type of intervention:


    Chemotherapy

59 (89)

    Radiation therapy

2 (3)

    Chemotherapy and radiation therapy

31 (48)

    Others

8 (12)

Study design:


    Parallel

97 (147)

    Cross over

3 (5)

No masking:

100 (152)

Expected difference in outcomes, and sample size prespecified:


    Yes

78 (119)

    No

9 (14)

    Missing data

13 (19)

a and b error prespecified:


    Yes

76 (116)

    No

11 (17)

    Missing data

13 (19)

Type of comparison:


   Active

91 (138)

   Placebo or no therapy

9 (14)

Primary endpoint:


    Survival

43 (65)

    Event free survival

39 (60)

    Others

18 (27)

Adequate allocation concealment:


    Yes

93 (142)

     No

7 (10)

Intention to treat analysis:

 

    Yes

93 (142)

    No or unclear

7 (10)

Description of drop outs:


    Yes

93 (141)

    No

7 (11)

*With intent to prolong survival or achieve cure.


Fig A Summary analyses according to publication status

Figure A [As supplied by authors]

  

 

 

 

Fig B Distribution of outcomes according to investigator’s judgment and achievement of statistical significance (126 trials involved 152 comparisons; there were missing data for 7% of studies regarding statistical significance. However, survival data from these studies were available for meta-analysis).

Figure B [As supplied by authors] 



Fig C Children’s Oncology Group - Forest Plot of all trials included in the analysis – Overall Survival

Fig C [As supplied by authors] Children’s Oncology Group - Forest Plot of all trials included in the analysis – Overall Survival

 



Random-effect analysis: Meta-Analysis




 


 

 



  


 




 

 

 


Fig D Summary analyses according to the methodological quality of trials and the choice of comparator. Notation same as in fig 2. The results were not affected by any of these methodological factors. ‡ Diff=difference; Calc=calculation.

Figure D [As supplied by authors]








Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview